Biomarcadores asociados a riesgo de síndrome metabólico: estudio en personal médico y administrativo de la facultad de ciencias de la salud UNAB - GENESIS II

dc.contributor.authorSerrano Díaz, Norma Ceciliaspa
dc.contributor.authorDíaz Martínez, Luis Alfonsospa
dc.contributor.authorPáez Leal, Carolina Maríaspa
dc.contributor.authorColmenares Mejía, Claudia Carolinaspa
dc.contributor.authorAcevedo Rueda, Sandra Milenaspa
dc.contributor.authorGuio Mahech, Elizabethspa
dc.contributor.authorBautista, Paula Katherinespa
dc.contributor.authorMartínez Contreras, Luz Ximenaspa
dc.contributor.authorMantilla Mora, Gerardospa
dc.contributor.cvlacSerrano Díaz, Norma Cecilia [0000066613]
dc.contributor.cvlacDíaz Martínez, Luis Alfonso [0000066621]
dc.contributor.cvlacPáez Leal, Carolina María [0000066656]
dc.contributor.googlescholarSerrano Díaz, Norma Cecilia [0000066613]
dc.contributor.googlescholarDíaz Martínez, Luis Alfonso [ABarFDsAAAAJ]
dc.contributor.googlescholarPáez Leal, Carolina María [BAPR3-cAAAAJ]
dc.contributor.orcidSerrano Díaz, Norma Cecilia [0000-0003-3532-2002]
dc.contributor.orcidDíaz Martínez, Luis Alfonso [0000-0002-4498-6639]
dc.contributor.orcidPáez Leal, Carolina María [0000-0002-0310-0125]
dc.contributor.researchgroupGrupo de Estudio Genético de Enfermedades Complejasspa
dc.contributor.researchgroupGrupo de Investigaciones Clínicasspa
dc.date.accessioned2020-10-27T14:20:29Z
dc.date.available2020-10-27T14:20:29Z
dc.date.issued2011-05-31
dc.description.abstractEl sÍndrome metabólico (SM) es factor de riesgo para mortalidad por enfermedad coronaria y diabetes mellitus. Se han propuesto nuevos marcadores de riesgo cardiovascular (RCV), con mejor capacidad pronóstica en la toma de medidas preventivas para disminuir la aparición o severidad de sus consecuencias. Objetivos: Establecer la prevalencia de SM y determinar el comportamiento de los factores de riesgo cardiovascular tradicionales y no convencionales entre hombres y mujeres de Bucaramanga, Colombia. MetodologÍa: GéNESIS es un estudio de cohorte prospectivo con evaluación en 2005 y 2010. Para la segunda fase, todos los participantes contestaron una encuesta semiestructurada, recibieron evaluación clÍnica, de presión arterial (PA) y parámetros antropométricos, asÍ como toma de sangre periférica en ayunas para medición de colesterol, HDL, triglicéridos, glicemia, PCR, IL- 6, Apo A-I y Apo B. Resultados: Para la segunda fase se evaluaron 66 empleados. Se encontró una prevalencia de SM del 18.2%. La población masculina presentó los mayores valores de PA, glucemia, triglicéridos, Apo B y relación Apo B/Apo A-I, comparado con las mujeres. En el estudio de seguimiento se evaluaron 44 personas en dos momentos (2005 y 2010), donde la población femenina evidenció un aumento significativo del PA, niveles de colesterol, HDL y glucemia, asÍ como descenso en los de PCR comparado con los hombres. Conclusión: El reconocimiento de los factores de riesgo tradicionales y no convencionales, y las diferencias de los mismos entre los géneros ayudarÍa a optimizar la estratificación del RCV y a futuro una mayor prevención de las enfermedades cardiovasculares.spa
dc.description.abstractenglishMetabolic syndrome (MS) is a risk factor for mortality from coronary heart disease and diabetes mellitus. New cardiovascular risk markers (CVR) have been proposed, with better prognostic capacity in taking preventive measures to reduce the appearance or severity of its consequences. Objectives: To establish the prevalence of MS and determine the behavior of traditional and unconventional cardiovascular risk factors among men and women from Bucaramanga, Colombia. Methodology: GENESIS is a prospective cohort study with evaluation in 2005 and 2010. For the second phase, all participants answered a semi-structured survey, received clinical evaluation, blood pressure (BP) and anthropometric parameters, as well as peripheral blood collection in fasting to measure cholesterol, HDL, triglycerides, glycemia, CRP, IL-6, Apo AI and Apo B. Results: For the second phase, 66 employees were evaluated. A prevalence of MS of 18.2% was found. The male population presented the highest values ​​of BP, glycemia, triglycerides, Apo B and Apo B / Apo A-I ratio, compared to women. In the follow-up study, 44 people were evaluated at two moments (2005 and 2010), where the female population showed a significant increase in BP, cholesterol, HDL and blood glucose levels, as well as a decrease in CRP levels compared to men. Conclusion: The recognition of traditional and unconventional risk factors, and their differences between genders, would help to optimize CVR stratification and in the future a greater prevention of cardiovascular diseases.eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga UNABspa
dc.identifier.issn2382-4603
dc.identifier.issn0123-7047
dc.identifier.repourlrepourl:https://repository.unab.edu.co
dc.identifier.urihttp://hdl.handle.net/20.500.12749/10224
dc.language.isospaspa
dc.publisherUniversidad Autónoma de Bucaramanga UNAB
dc.publisher.facultyFacultad Ciencias de la Salud
dc.publisher.programPregrado Ingeniería Biomédica
dc.relationhttps://revistas.unab.edu.co/index.php/medunab/article/view/1377/1349
dc.relation.referencesWorld Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management o total cardiovascular risk. WHO Library Cataloguing-in.Publication Data. 2007
dc.relation.referencesBraun LT. Cardiovascular disease strategies for risk cardiovascular risk. .assessment and modification. J Cardiovasc Nurs 2006
dc.relation.referencesUS Department of Health and Human Services. APublic practice. Nat Clin Pract .Health Action Plan to Prevent Heart Disease and Stroke: Executive Summary and Overview. Atlanta, GA: US Department of Health and Human Services, Centers or Disease Control and Prevention; 2003. Disponible .en:http://www.cdc.gov/dhdsp/library/action_plan/2008_update/index.htm
dc.relation.referencesMathers C, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoSMed. 2006 Nov; 3(11): e442, 2011-2030
dc.relation.referencesLópez A, Mathers C, Ezzati M, Jamison D, Murray C. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367:1747-57
dc.relation.referencesMurray C, López A. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349:1498-504
dc.relation.referencesOrganizaciónPanamericanadelaSalud–Organización Mundial de la Salud - Ministerio de la protección social. Situación de Salud en Colombia. Indicadoresbásicos2008.Disponibleen:http://www.minproteccionsocial.gov.co/salud/Paginas/INDICADORESBASICOSSP.aspx
dc.relation.referencesCubillos-Garzón L, Casas J, Morillo C, Bautista L. Congestive heart failure in Latin America: The next epidemic. Am Heart J 2004; 147:412–7
dc.relation.referencesBautista L, Orostegui M, Vera L, Prada G, Orozco L, et al. Prevalence and impact of cardiovascular risk factors in Bucaramanga, Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI/CARMEN) baseline survey. Eur J Cardiovasc Prev Rehabil. 2006; 13:769-75
dc.relation.referencesAlberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, et al. Harmonizing the Metabolic Syndrome AJoint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-5
dc.relation.referencesMalik s, Wong N, Franklin S, Kamath T, L'Italien G, et al. Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults. Circulation 2004; 110:1245-50
dc.relation.referencesSmulders Y, Thijs A, Twisk J. New cardiovascular risk determinants do exist and are clinically useful. Eur Heart J 2008; 29:436-40
dc.relation.referencesHlatky M, Greenland P, Arnett D, Ballantyne C, Criqui M, et al. Criteria for Evaluation of Novel Markers of Cardio-vascular Risk. AScientific Statement From the American Heart Association. Circulation 2009; 119:2408-16
dc.relation.referencesMadjid M, Ali M, Willerson JT. Lipoprotein-associated phospholipaseA2asaNovelRiskMarkerforCardiovascular Disease. ASystematic Review of the Literature. Texas Heart Inst J 2010; 37:25-39
dc.relation.referencesCastelli W, Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996; 124 Suppl:S1-9
dc.relation.referencesKhot U, Khot M, Bajzer C. Prevalence of conventional risk factors in patients with coronary heart disease AMA2003; 290:898-904
dc.relation.referencesShah S, Newby L. C-reactive protein: Anovel marker of cardiovascular risk. Cardiol Rev 2003; 11:169-79
dc.relation.referencesSuzuki T, Katz R, Swords N, Zakai N, LeWinter M. .Metabolic syndrome, inflammation, and incident heart ailure in the elderly. The Cardiovascular Health Study. Circ Heart Fail 2008; 1:242-8
dc.relation.referencesLanas F, Avezum A, Bautista L, Díaz R, Luna M, et al. Risk Factors for Acute Myocardial Infarction in Latin America: The INTERHEARTLatin American Study. Circulation 2007; 115:1067-74
dc.relation.referencesPinzón J, Serrano N, Díaz LA, Mantilla G, Velasco H. .Impacto de las nuevas definiciones en la prevalencia del síndrome metabólico. Biomédica 2007; 27:172-9
dc.relation.referencesDíaz LA, Serrano N, Pinzón J, Mantilla G, Velasco H. Ausencia de asociación entre síndrome metabólico y trastorno depresivo en adultos colombianos. Rev Méd Chile 2007; 135:990-6
dc.relation.referencesFord E, Giles W, Mokdad A. The distribution of 10-year risk for coronary heart disease among U.S. adults Findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol 2004 43:1791-6
dc.relation.referencesBatsis J, Nieto R, López F. Metabolic syndrome: from .global epidemiology to individualized medicine. Clin Pharmacol Ther 2007; 82:509-24
dc.relation.referencesAlbertiK,ZimmetP,ShawJ.Themetabolic syndrome—a new worldwide definition. Lancet 2005 366:1059-62
dc.relation.referencesBalkau B, Charles M. Comment on the provisional .report from the WHO consultation. European Group fo the Study of Insulin Resistance (EGIR). Diabet Med 1999; 16:442-3
dc.relation.referencesAnand S, Islam S, Rosengren A, Grazia M, Steyn K. Risk factors for myocardial infarction in women and men: insights from the INTERHEARTstudy. Eur Heart J 2008; 29:932-40
dc.relation.referencesRidker P, Buring J, Cook N, Rifai N. Cardiovascular .events: An 8-year follow-up of 14,719 initially healthy C- reactive protein, the metabolic syndrome, and risk of inthemetabolicsyndromeandtheirroleforincident American women. Circulation 2003; 107: 391-
dc.relation.referencesBlaak E. Sex differences in the control of glucose homeostasis. Curr Opin Clin Nutr Metab Care 2008; 1:500-4
dc.relation.referencesRen J, Kelley R. Cardiac health in women with metabolic .syndrome:clinicalaspectsandpathophysiology Obesity 2009; 17:1114–23
dc.relation.referencesRazzouk L, Muntner P. Ethnic, gender, and age-related .differences in patients with the metabolic syndrome Curr Hypertens Rep 2009; 11:127-32
dc.relation.referencesTan Y, Gast G, Van der Schouw Y. Gender differences in factors for coronary heart disease. Maturitas 2010; 1999; 16:442-3. 65:149-60
dc.relation.urihttps://revistas.unab.edu.co/index.php/medunab/article/view/1377
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.sourceMedUNAB; Vol. 14 Núm. 1 (2011): Enfermería, Hepatitis B, Biomarcadores; 40-47
dc.subject.keywordsMetabolic syndrome
dc.subject.keywordsCardiovascular risk
dc.subject.keywordsCardiovascular risk markers
dc.subject.lembBioquímica
dc.subject.lembProfesión médica
dc.subject.proposalSíndrome metabólico
dc.subject.proposalRiesgo cardiovascular
dc.subject.proposalMarcadores de riesgo cardiovascular
dc.titleBiomarcadores asociados a riesgo de síndrome metabólico: estudio en personal médico y administrativo de la facultad de ciencias de la salud UNAB - GENESIS II
dc.title.translatedAssociated biomarkers with metabolic syndrome risk: A study among medical and administrative staff of the UNAB health science faculty - GENESIS II
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localArtículospa
dc.type.redcolhttp://purl.org/redcol/resource_type/ART

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
2011_Biomarcadores_asociados_a_riesgo_de_síndrome_metabólico.pdf
Tamaño:
119.6 KB
Formato:
Adobe Portable Document Format
Descripción:
Articulo